Policy & Medicine

DEA Issues New Regulations on Prescribing Controlled Substances

Thomas Sullivan Jan 17, 2025 0

In the final days of the Biden administration the Drug Enforcement Administration (DEA) has issued new regulations on who can prescribe controlled substances. This is the agencies third attempt at a proposed rule on the topic. These updates from the DEA have sparked a vigorous debate among stakeholders, highlighting the balance between…

Policy and Medicine Compliance Update – November 2023…

Thomas Sullivan Dec 1, 2023 0

Policy and Medicine Compliance Update October 2023 Issue…

Thomas Sullivan Oct 20, 2023 0

DEA Issues New Regulations on Prescribing Controlled Substances

HHS AI Strategic Plan 2025

The U.S. Department of Health and Human Services (HHS) has unveiled a comprehensive Strategic Plan aimed at integrating Artificial Intelligence (AI) into its operations which the stated aim is to…

Second Federal Trade Commission Report on Pharmacy Benefit…

The Federal Trade Commission (FTC) released its second interim staff report “Specialty Generic Drugs a Growing Profit Center for Vertically Integrated Pharmacy Benefit Managers” as part of an ongoing…

Transforming U.S. Healthcare: A Look at President Trump’s…

President Donald Trump's lineup of nominees for top healthcare positions is set to introduce significant reforms aimed at enhancing efficiency, patient choice, and reducing bureaucratic red tape in…

GAO Finds Hospital Transparency Data Lacking

The Government Accountability Office (GAO) released a report on the hospital pricing transparency initiative, finding that the Centers for Medicare and Medicaid Services (CMS) needs more information…

This Week in Policy and Medicine – January 12, 2025

Welcome to this week's edition of This Week in Policy and Medicine, now available on Spotify and your favorite podcast platforms. Dive into the pivotal developments covered in our recent articles:…

John Marshall Unscripted Shaping the Future of Pancreatic…

In a compelling episode of "Oncology Unscripted," Dr. John Marshall engages in a profound dialogue with Julie Fleshman, a vanguard in the realm of pancreatic cancer advocacy. Fleshman, who leads the…

Federal Court Upholds Dismissal of Medicare Advantage False…

Recently, the United States Court of Appeals for the Eighth Circuit affirmed the lower court’s dismissal of a Medicare Advantage (MA) False Claims Act (FCA) liability case. In United States ex rel.…

Second Circuit Introduces At-Least-One-Purpose Rule to…

The United States Court of Appeals for the Second Circuit recently revived a whistleblower lawsuit against Novartis, marking a development in the enforcement of the Anti-Kickback Statute (AKS). This…

HEARTS (Health Education, Awareness, Research, and Training in…

On December 26, 2024, President Biden signed the HEARTS Act, legislation designed to enhance cardiac safety in schools across the United States. Supported vigorously by the American Heart Association…

Eight Individuals Indicted in Medicaid Fraud Scheme for Adult…

The Department of Justice (DOJ) recently unsealed an indictment in federal court in Brooklyn, New York, that charges eight defendants for their alleged roles in a scheme to defraud Medicaid. According…

2025 Healthcare Meetings and Conference Calendar

2025 will be a busy year for healthcare. Here is a list of healthcare conferences and links to registration. Special thanks to Peter Grant and Global Healthcare LLC (GHC) for providing the initial…